139 related articles for article (PubMed ID: 16095491)
1. Induction of obliterative airway disease by anti-HLA class I antibodies.
Maruyama T; Jaramillo A; Narayanan K; Higuchi T; Mohanakumar T
Am J Transplant; 2005 Sep; 5(9):2126-34. PubMed ID: 16095491
[TBL] [Abstract][Full Text] [Related]
2. Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts.
Smith MA; Jaramillo A; SivaSai KS; Naziruddin B; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Jan; 73(2):186-93. PubMed ID: 11821728
[TBL] [Abstract][Full Text] [Related]
3. Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells.
Higuchi T; Jaramillo A; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Sep; 74(5):646-51. PubMed ID: 12352880
[TBL] [Abstract][Full Text] [Related]
4. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome.
Jaramillo A; Smith CR; Maruyama T; Zhang L; Patterson GA; Mohanakumar T
Hum Immunol; 2003 May; 64(5):521-9. PubMed ID: 12691702
[TBL] [Abstract][Full Text] [Related]
5. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.
Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T
J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
7. Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor.
Smith CR; Jaramillo A; Lu KC; Higuchi T; Kaleem Z; Mohanakumar T
Transplantation; 2001 Nov; 72(9):1512-8. PubMed ID: 11707738
[TBL] [Abstract][Full Text] [Related]
8. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.
Saini D; Angaswamy N; Tiriveedhi V; Fukami N; Ramachandran S; Hachem R; Trulock E; Meyers B; Patterson A; Mohanakumar T
J Heart Lung Transplant; 2010 Dec; 29(12):1330-6. PubMed ID: 20691611
[TBL] [Abstract][Full Text] [Related]
10. B Cell-Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti-Major Histocompatibility Complex-Induced Obliterative Airway Disease.
Xu Z; Ramachandran S; Gunasekaran M; Nayak D; Benshoff N; Hachem R; Gelman A; Mohanakumar T
Am J Transplant; 2016 Apr; 16(4):1173-82. PubMed ID: 26844425
[TBL] [Abstract][Full Text] [Related]
11. Induction of obliterative airway disease in murine tracheal allografts by CD8+ CTLs recognizing a single minor histocompatibility antigen.
Higuchi T; Maruyama T; Jaramillo A; Mohanakumar T
J Immunol; 2005 Feb; 174(4):1871-8. PubMed ID: 15699113
[TBL] [Abstract][Full Text] [Related]
12. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton TR; Shorthouse R; Huang X; Reitz BA; Morris RE
Transplantation; 1997 Aug; 64(3):373-83. PubMed ID: 9275099
[TBL] [Abstract][Full Text] [Related]
13. An obligatory role for lung infiltrating B cells in the immunopathogenesis of obliterative airway disease induced by antibodies to MHC class I molecules.
Fukami N; Ramachandran S; Takenaka M; Weber J; Subramanian V; Mohanakumar T
Am J Transplant; 2012 Apr; 12(4):867-76. PubMed ID: 22233464
[TBL] [Abstract][Full Text] [Related]
14. Specific immune responses against airway epithelial cells in a transgenic mouse-trachea transplantation model for obliterative airway disease.
Qu N; de Haan A; Harmsen MC; Kroese FG; de Leij LF; Prop J
Transplantation; 2003 Oct; 76(7):1022-8. PubMed ID: 14557747
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
16. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation.
Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T
Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756
[TBL] [Abstract][Full Text] [Related]
17. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
Kelly KE; Hertz MI; Mueller DL
Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
[TBL] [Abstract][Full Text] [Related]
18. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
19. Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.
Basha HI; Ramachandran S; Tiriveedhi V; Takenaka M; Subramanian V; Nath DS; Benshoff N; Patterson GA; Mohanakumar T
Transplantation; 2013 Jan; 95(2):293-300. PubMed ID: 23325004
[TBL] [Abstract][Full Text] [Related]
20. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha.
Farivar AS; Mackinnon-Patterson B; McCourtie AS; Namkung J; Ward PA; Mulligan MS
Exp Mol Pathol; 2005 Jun; 78(3):190-7. PubMed ID: 15924870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
